title: Omalizumab in the treatment of aspirin-exacerbated respiratory disease.
authors: Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors: Karl-Christian
authors: KC
authors: Bergmann
authors: Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors: Torsten
authors: T
authors: Zuberbier
authors: Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: mkc@soton.ac.uk.
authors: Martin K
authors: MK
authors: Church
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D055963:Asthma, Aspirin-Induced / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects* / Q000276:immunology / Q000503:physiopathology; D008875:Middle Aged; D000069444:Omalizumab / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000069444:Omalizumab